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a b s t r a c t
To gain insight into liver and pancreas development, we investigated the target of 2F11, a monoclonal
antibody of unknown antigen, widely used in zebraﬁsh studies for labeling hepatopancreatic ducts.
Utilizing mass spectrometry and in vivo assays, we determined the molecular target of 2F11 to be
Annexin A4 (Anxa4), a calcium binding protein. We further found that in both zebraﬁsh and mouse
endoderm, Anxa4 is broadly expressed in the developing liver and pancreas, and later becomes more
restricted to the hepatopancreatic ducts and pancreatic islets, including the insulin producing ß-cells.
Although Anxa4 is a known target of several monogenic diabetes genes and its elevated expression is
associated with chemoresistance in malignancy, its in vivo role is largely unexplored. Knockdown of
Anxa4 in zebraﬁsh leads to elevated expression of caspase 8 and Δ113p53, and liver bud speciﬁc
activation of Caspase 3 and apoptosis. Mosaic knockdown reveal that Anxa4 is required cell-
autonomously in the liver bud for cell survival. This ﬁnding is further corroborated with mosaic anxa4
knockout studies using the CRISPR/Cas9 system. Collectively, we identify Anxa4 as a new, evolutionarily
conserved hepatopancreatic factor that is required in zebraﬁsh for liver progenitor viability, through
inhibition of the extrinsic apoptotic pathway. A role for Anxa4 in cell survival may have implications for
the mechanism of diabetic ß-cell apoptosis and cancer cell chemoresistance.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Extensive genetic and morphogenetic similarities between the
mammalian and ﬁsh hepatopancreatic system validate the zebra-
ﬁsh as a practical vertebrate model system for studying liver and
pancreas development. Discovering new factors expressed in the
developing zebraﬁsh hepatopancreatic system may therefore yield
insight into human liver and pancreas development. The mono-
clonal antibody (mAb) 2F11 is widely used to mark the developing
and adult zebraﬁsh hepatopancreatic ducts (HPDs), as well as
enteroendocrine cells (Crosnier et al., 2005; Curado et al., 2010;
Delous et al., 2012; Dong et al., 2007; EauClaire et al., 2012;
Lancman et al., 2013; Manfroid et al., 2012; Matthews et al., 2011;
Ninov et al., 2012). Particularly, 2F11 marks the intestinal secretory
cells, extra-HPDs (common bile duct, cystic duct, hepatopancreas
ampulla, extra-hepatic duct and extra-pancreatic duct), gallblad-
der, intra-pancreatic (Dong et al., 2007), and intra-hepatic ducts
(Lorent et al., 2010; Matthews et al., 2008). However, the target
antigen bound by this mAb is not known—as 2F11 was among
other randomly raised mAbs against the lysate of adult zebraﬁsh
gut (Crosnier et al., 2005). Identifying the target bound by 2F11
will shed new light on published works in which this mAb was
employed, contribute to a short list of genes that are speciﬁcally
expressed in the hepatopancreatic ductal system and intestinal
secretory cells, and yield new perspectives into hepatopancreas
development.
In this study, we demonstrated that the antigen of 2F11 is
zebraﬁsh Anxa4. Anxa4 belongs to the Annexin family of calcium-
and phospholipid-binding proteins, which from cell-based studies,
have been implicated in multiple cellular functions including
endocytosis, exocytosis, and ion ﬂuxes (Gerke and Moss, 2002).
Zebraﬁsh Anxa4 is distinct from other zebraﬁsh Annexins in that it
has a short, highly conserved N-terminal domain that is more
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similar to mammalian Anxa4 orthologues (Farber et al., 2003).
Human ANXA4 is predominantly detected in the epithelial cells of
several organs, including the liver and pancreas (Dreier et al.,
1998). In vitro studies suggest that it inhibits Ca2þ activated Cl
conductance (Chan et al., 1994) and reduces the water and
proton permeability of the membrane possibly through modulat-
ing membrane rigidity (Hill et al., 2003). ANXA4 expression is
increased in many cancer types, including cancers of renal, gastric,
colonic, ovarian, and cervical origins (Duncan et al., 2008; Lin et
al., 2008; Miao et al., 2009; Shen et al., 2004; Toyama et al., 2012;
Zimmermann et al., 2004). Its expression has been associated with
loss of cell-to-cell adhesion, increased metastasis, and chemo-
resistance, and therefore is now regarded as a potential cancer
diagnostic and therapeutic target (Kim et al., 2010; Masuishi et al.,
2011). In vitro studies suggest that in response to cytotoxic stress,
ANXA4 exhibits an anti-apoptotic effect (Han et al., 2000; Kim
et al., 2009) by activating NF-κB transcriptional activity (Jeon et al.,
2010; Sohma et al., 2003). Also, pancreas expression of ANXA4 is
downstream of several monogenic diabetes genes, including PDX1,
HNF1A, and HNF4A (Bolotin et al., 2010; Servitja et al., 2009;
Svensson et al., 2007), suggesting potential roles for ANXA4 in
diabetes.
Only limited in vivo functional analysis of Anxa4 has been
reported. Speciﬁc loss of Anxa4 from the mouse urothelium caused
no detectable phenotypes. However other Annexins were suggested
to have redundant roles (Hill et al., 2008). In Xenopus laevis, there are
two paralogs of this gene, anxa4a and anxa4b. Knockdown of anxa4a,
which is expressed in the pronephros but not in the liver, affects
pronephros development (Masse et al., 2007; Seville et al., 2002). The
in vivo role of anxa4b, which is expressed in the liver, was not
described. Therefore, Anxa4 function during foregut endoderm
development has yet to be investigated in animal models.
In our present study, we determined that the 2F11 mAb targets
Anxa4 in zebraﬁsh, demonstrating an efﬁcient approach for
identifying the antigen of an orphan antibody. We show that
hepatopancreas expression of Anxa4 in zebraﬁsh and mouse is
conserved. Our in vivo functional studies using zebraﬁsh embryos,
suggest that Anxa4 plays a role in maintaining liver cell survival by
inhibiting the extrinsic apoptotic pathway. Mosaic studies suggest
that Anxa4 functions cell-autonomously to block apoptosis speci-
ﬁcally in the liver bud. This is the ﬁrst in vivo investigation to link
Anxa4 to cell viability, consistent with previous in vitro studies.
Results
The antigen of mAb 2F11 is expressed in hepatopancreatic progenitors
It has been well documented that the 2F11 mAb is a robust
marker for hepatopancreatic ducts and intestinal secretory cells in
zebraﬁsh. To gain further insight into the 2F11 target antigen, we
examined its expression pattern at different stages of hepatopan-
creas development in Tg(sox17:GFP) embryos, which express GFP
in the early endoderm (Mizoguchi et al., 2008). Initial budding of
the zebraﬁsh liver occurs at 28 hpf (hours post fertilization) (Field
et al., 2003b). As with mammals, the mature zebraﬁsh pancreas
arises from the fusion of the dorsal and ventral pancreas. The
dorsal pancreas emerges from the dorsal foregut endoderm at
24 hpf. At 32 hpf, the ventral pancreas appears posterior to and
contiguous with the liver bud. By 40 hpf, the ventral pancreas
begins to fuse with the dorsal pancreas, which has separated from
the dorsal endoderm (Field et al., 2003a). At 20 hpf, 2F11 marks
the GFP positive foregut endoderm, in a region posterior to the
pharyngeal endoderm (Fig. 1a). At this stage, low level 2F11
staining with membrane localization is observed broadly in the
foregut endoderm. Within this domain, the dorsal pancreatic cells
are strongly marked, with labeling throughout the cell. The
pronephric ducts are also labeled by 2F11. By 26 hpf, while low
level 2F11 remains broad along the foregut, high level 2F11
becomes restricted to the dorsal pancreas bud (Fig. 1b). The
zebraﬁsh dorsal pancreas is composed primarily of endocrine
cells, which can be visualized using Tg(neuroD:EGFP) embryos
(Obholzer et al., 2008). We found that the high level 2F11 staining
is coincident with the dorsal pancreas endocrine cells in 26 hpf Tg
(neuroD:EGFP) embryos (Fig. 1c). All neuroD:EGFP cells in the
dorsal pancreas appears to have varying levels of 2F11 (Fig. 1c″
and c″0), indicating that 2F11 marks all endocrine cell types at
this stage.
At 30 hpf, as the liver bud becomes prominent, 2F11 staining is
markedly increased in the liver bud, exhibiting broad intracellular
localization (Fig. 1d). The ventral pancreas bud also shows elevated
2F11 labeling when it initially appears at 34 hpf (Fig. 1e). At these
stages, low-level 2F11 labeling persists broadly throughout the
foregut. In the liver and ventral pancreas buds, 2F11-marked cells
also express Prox1, one of the earliest liver and pancreas progeni-
tor markers in zebraﬁsh (Ober et al., 2006), conﬁrming that the
expression of the antigen of 2F11 is elevated in the early devel-
oping liver and ventral pancreas. Also, 2F11 labeling is stronger on
the ventral side of the foregut endoderm (Fig. 1d″0 and e″0; larger
image of f″0 is shown in Fig. S1). As the liver and pancreas grow out
laterally, 2F11 continues to broadly label the entire hepatopan-
creas region, and becomes heightened in cells between the Prox1
positive liver and ventral pancreas domains (Fig. 1e and f),
suggesting that the antigen of 2F11 is speciﬁcally up-regulated in
the presumptive extra-HPDs. From 42 to 48 hpf, as 2F11 staining
continues to be elevated in the ventral endoderm, the broad
labeling in the presumptive extra-HPDs becomes more localized
to the plasma membrane (Fig. 1f and g). After the dorsal pancreas
has fused with the ventral pancreas, 2F11 staining of the endocrine
cells in the principal islets is decreased (Fig. 1g).
By 80 hpf, the epithelial cells between the liver and pancreas
become columnar and organize into ducts. 2F11 staining remains
high in these ducts, showing lateral–basal localization (Fig. 1h).
Within the liver and pancreas, 2F11 marks the intrapancreatic
ducts and intrahepatic biliary ducts, as previously reported (Dong
et al., 2007; Lorent et al., 2010; Matthews et al., 2008). Neogenic
endocrine cells found outside the principal islet become more
apparent after 60 hpf, presumably arising from the 2F11 labeled
ducts. In Tg(neuroD:EGFP) embryos, a subset of these GFP labeled
new endocrine cells are also positive for 2F11 (Fig. S2a and b0),
consistent with 2F11 labeling new endocrine cells in juvenile
zebraﬁsh (Matsuda et al., 2013). We also observed that in the liver
and pancreas, there is moderate to low level 2F11 labeling of non-
ductal cell types, particularly in peripheral cells along the proximal
regions of these organs (not shown).
Our analysis of 2F11 labeling in the developing zebraﬁsh
endoderm reveals that its antigen is dynamically expressed during
hepatopancreas organogenesis. It appears broadly in the foregut
and becomes gradually restricted to the hepatopancreas progeni-
tors and then to hepatopancreatic ducts. Its intracellular localiza-
tion is also dynamic, initially in whole cells and then becoming
more restricted to the membrane. This progression of intracellular
localization may correlate with the differentiation state of the cell
and suggests the target factor may be involved in multiple cellular
processes. This intriguing expression pattern led us to seek the
identity of the 2F11 antigen.
Annexin A4 is the antigen of 2F11 mAb
To identify a candidate target for 2F11, we used a mass
spectrometry approach. The 2F11 antibody was used to immuno-
precipitate possible antigens from the lysate of zebraﬁsh embryos
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at 72 hpf, when 2F11 foregut labeling is robust. The proteins
captured were then separated by PAGE gel electrophoresis under
reducing conditions, where a clear band was resolved that was not
the immunoglobulin light or heavy chains (Fig. 2a). That band,
appearing between 28 and 39 kDa, was cut out and in-gel digested
into small peptides by Trypsin. These peptides were then sepa-
rated by HPLC and analyzed by tandem Mass spectrometry (MS/
MS). All peptide sequences identiﬁed precisely matched various
regions of the zebraﬁsh Annexin A4 protein (Anxa4) (Fig. 2b).
Anxa4 is a 35.6 kDa protein, consistent with the size of the band
analyzed. Anxa4 belongs to the Annexin family of Ca2þ and
phospholipid binding proteins and is often associated with the
inner leaﬂet of the plasma membrane (Gerke et al., 2005). This
intracellular localization is consistent with our immunohisto-
chemical data showing that 2F11 can mark the plasma membrane.
Annexins are thought to form multimers (Gerke et al., 2005),
which may explain the multiple higher bands previously observed
on a 2F11 western blot run under non-reducing conditions
(Crosnier et al., 2005). These ﬁndings collectively support Anxa4
as a strong candidate target of 2F11.
We next assessed whether 2F11 labeling corresponds with anxa4
transcript expression. In situ hybridization (ISH) studies revealed that
anxa4 mRNA was expressed in the ﬂoor plate, hypochord, and
pronephric ducts at 24 hpf, as well as in the liver and gallbladder
at 3 dpf (days post fertilization) (Farber et al., 2003). These domains
of anxa4 mRNA expression strongly coincide with tissues labeled by
2F11, including intrahepatic biliary ducts (Lorent et al., 2010;
Matthews et al., 2008), extra-hepatopancreatic ducts, and gallbladder
at 3 dpf (Dong et al., 2007). We found 2F11 also labels the ﬂoor plate,
the hypochord and pronephric ducts (Fig. 1 and data not shown).
Therefore the reported expression of anxa4 mRNA corresponds well
with 2F11 labeling. We further examined the global expression of
anxa4 mRNA during development via whole mount ISH. At 18 hpf,
anxa4 transcripts can be detected in the region of the foregut
endoderm and pronephric duct precursors (Fig. 2c). By 26 hpf, high
levels of anxa4 transcripts appear in the dorsal pancreas (Fig. 2d and
e). Similar to 2F11 labeling, anxa4 is expressed in the liver bud and its
expression domain extends posteriorly towards the dorsal pancreas
from 30 to 36 hpf (Fig. 2f and g). In reference to GFP expression in
Tg(sox17:GFP) embryos, anxa4 transcripts appear within the liver,
ventral pancreas and dorsal pancreas regions of the endoderm
(Fig. 2h and i0). By 47 hpf, anxa4 transcripts are found throughout
most of the hepatopancreas domain with the proximal liver exhibit-
ing stronger signals (Fig. 2j). 2F11 staining has a similar pattern
except that it is higher in the extra-HPD region (between liver and
pancreas) than in liver or pancreas (Fig. 2k and k0). Differences
between Anxa4 protein and transcript production and turnover may
account for this discrepancy between protein and transcript expres-
sion levels. We conclude that during early organogenesis, anxa4
transcripts are expressed in the same foregut endoderm tissue that is
labeled by 2F11, including the dorsal pancreas, liver, ventral pancreas,
and presumptive ducts connecting these organs.
At 80 hpf, anxa4 transcripts appear elevated in the extra-
hepatopancreatic ducts and gallbladder. Within the pancreas and
liver, anxa4 expression becomes more restricted to the intrapan-
creatic ducts and intrahepatic ducts, respectively (Fig. 2l). The
anxa4 transcripts are expressed in a ring of cells around the
principal islet in the pancreatic head and in a strip of cells in the
middle of the pancreatic tail, correlating to the developing
intrapancreatic ducts. In the liver, it is expressed in a distinct
branched pattern, consistent with the structure of intrahepatic
biliary ducts. Therefore anxa4 probe appears to label the hepato-
pancreatic ducts, consistent with 2F11 (Fig. 2m and m0). We found
anxa4 is also expressed in individual cells scattered in the gut,
consistent with intestine secretory cells, which are also labeled by
2F11 (Crosnier et al., 2005). Outside of the endoderm, anxa4
transcripts appear in the mesenchymal cells around the swim
bladder, similar to 2F11 labeling. In summary, the temporal–spatial
expression pattern of anxa4 transcripts, in both endoderm and
non-endoderm tissues, coincides with 2F11 labeling, further sup-
porting that Anxa4 is the target of the 2F11 mAb.
To functionally test whether Anxa4 is recognized by 2F11, we
examined whether knockdown of Anxa4 translation by antisense
morpholinos (MO) leads to a reduction of 2F11 labeling. We used
two different MOs to disrupt Anxa4 protein expression. MO1
blocks Anxa4 translation initiation, whereas MO2 disrupts normal
splicing of anxa4 by blocking the splicing donor site of Intron 4.
Disruption of this splicing donor site is predicted to cause skipping
of Exon 4, leading to translation from Exon 3 directly into Exon 5
(Fig. 3a). This would result in a translational frame-shift, leading to
a premature stop codon in Exon 5. The effectiveness of MO2 was
assessed by RT-PCR, which demonstrated the presence of a mis-
spliced transcript and a reduction of the normally spliced tran-
scripts in the MO2 morphants (MO injected animals) (Fig. 3b). The
sequence of the mis-spliced transcript lacks Exon 4 and reads
directly from Exon 3 into Exon 5, consistent with our prediction
(Fig. 3c). Translation of anxa4 transcript starts in Exon 3, which
codes for the ﬁrst 3 amino acids of Anxa4. With only the ﬁrst
3 amino acids from Exon 3 in frame, it is unlikely that the resulting
protein will contain the epitope recognized by 2F11. Following
injection of these anxa4 MOs, we used western blot analysis to
examine 2F11 bands from the whole embryo lysate of the 48 hpf
and 72 hpf morphants. We found 2F11 bands were markedly
reduced for morphants as compared to uninjected controls.
Further, immunohistochemical analysis of morphant Tg(sox17:
GFP) embryos injected with either MO show signiﬁcantly reduced
2F11 labeling in their hepatopancreas system indicating that the
2F11 target antigen is reduced when anxa4 translation is com-
prised (Fig. 3e–g0). The severe loss of 2F11 labeling caused by
anxa4 speciﬁc antisense MOs in both whole mount immuno-
staining and western blot provides functional evidence that Anxa4
is the target of 2F11 antibody. Together with similar expression
patterns between anxa4 mRNA and 2F11 antibody staining, and
the identiﬁcation of the protein pulled down by 2F11 via peptide
Fig. 1. 2F11 mAb labels hepatopancreas progenitors during organogenesis. (a) and (a0) Ventral view of a 20 hpf Tg(sox17:GFP) foregut showing broad low 2F11 labeling
(turquoise arrowheads), and higher labeling in dorsal pancreas cells (turquoise arrows) and the pronephric ducts (white arrows). (b) and (c0) Lateral view of 26 hpf Tg(sox17:
GFP) (b) and Tg(neuroD:EGFP) (c) foregut showing 2F11 labels the dorsal pancreas (dP) with a single focal plane shown in (c″) and (c″0). (d)–(g″0) Ventral view of the Tg(sox17:
GFP) foregut with Prox1 and 2F11 labeling at 30, 34, 42 and 48 hpf; (d″0), (e″0), (f″0), (g″0) digital sections along X, Y, and Z axes showing higher 2F11 staining on the ventral
side of the endoderm (green lines indicate the positions of the X-axis sections, right insets; red lines indicate the positions of the Y-axis sections, top insets, a larger image of
(f″0) is shown in Fig. S1). (d)–(d″) 2F11 staining increases in the Prox1þ budding liver (L) at 30 hpf. (e)–(e″) At 34 hpf, 2F11 labeling increases in the Prox1þ ventral pancreas
(vP) with broad cellular localization. Note the elevated staining in cells between the liver and ventral pancreas (white arrowhead). (f) and (f″) At 42 hpf, 2F11 labeling
increases further in the cells between liver and ventral pancreas with broad cellular localization. (g) and (g″) At 48 hpf, 2F11 labels the entire hepatopancreas system with
elevated staining and non-nuclear localization (white arrowheads) in cells between the liver and pancreas (P). (h) Ventral view of the Tg(ptf1a:GFP);Tg(lfabf:ds-Red) foregut at
80 hpf showing 2F11 labeling becomes restricted to the gallbladder (GB; yellow arrow) and ducts, including intrapancreatic ducts (white arrowheads), intrahepatic ducts
(black arrowheads), and extra hepatopancreatic ducts (yellow arrowheads). (h0) Digital sections along X, Y, and Z axes showing higher 2F11 staining in the ventral region of
the ducts. (i) and (i0) Higher magniﬁcation of (h0) (white square inset) showing 2F11 basal–lateral cellular localization in ductal columnar epithelium where it does not
overlap with apically restricted Cadherin (yellow arrows).
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Fig. 2. Anxa4 is bound by 2F11 and is expressed in tissues labeled by 2F11. (a) and (b) A 2F11 immuno-precipitated band (arrow in (a)) was analyzed by peptide mass
ﬁngerprinting, yielding peptide sequences (colored text in (b)) that match zebraﬁsh Anxa4. (c)–(g0) Anxa4 is expressed in the developing zebraﬁsh foregut (orange arrow),
pronephric ducts (magenta arrowheads), dorsal pancreas (yellow arrows), liver bud (red arrowheads), lateral lines (turquoise arrowheads), and hatching gland (green
arrowheads). (h)–(k0) The ventral view of Tg(sox17:GFP) with anxa4 transcript (h) and (j) or 2F11 labeling (i), (i0), (k) and (k0) of the liver (L), ventral pancreas (vP), and dorsal
pancreas (dP) at 34 hpf (h) and (I0) and 47 hpf (j) and (k0). (l) and (m0) At 80 hpf, both anxa4 transcripts (l) and 2F11 (m) and (m0) are found in the gallbladder (GB),
hepatopancreatic ducts, including extrahepatic duct (EHD), common bile duct (CBD), extrapancreatic duct (EPD), intrapancreatic duct (IPD) and intrahepatic duct (IHD),
intestinal secretory cells (yellow arrowheads), and mesenchymal cells around the swim bladder (turquoise arrowheads).
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mass ﬁngerprinting, we conclude that the antigen recognized by
the mAb 2F11 is zebraﬁsh Anxa4.
Conserved Anxa4 expression in the vertebrate liver and pancreas
To assess the expression of Anxa4 during mammalian liver and
pancreas development, we examined its protein expression in
parafﬁn sections of mouse embryos. From embryonic day 12 (E12)
to E14, we found Anxa4 is broadly co-expressed with Prox1, a
hepatoblast marker (Sosa-Pineda et al., 2000). In the E12 pancreas,
Anxa4 appears to be expressed in the entire pancreatic epithelium,
including Sox9 and Glucagon expressing cells (Fig. 4b and b″). At
E14, Anxa4 remains expressed in both the high Sox9 positive cells
in the primitive ducts and the low Sox9 positive cells near the tips
of the branches. It is also expressed in the islet, including the
Glucagon expressing cells (Fig. 4d and d″). These ﬁndings suggest
that similar to zebraﬁsh, mouse Anxa4 is broadly expressed in the
developing liver and pancreas.
In the mouse liver and pancreas of the postnatal day 25 (P25),
Anxa4 is expressed in cells with high levels of E-Cadherin,
suggesting that elevated Anxa4 expression is restricted to the
intrahepatic ducts and intrapancreatic ducts (Fig. 4e and f). Anxa4
expression is also observed in pancreatic islets, showing co-
expression with Glucagon in α-cells and with Insulin in β-cells.
In islets, Anxa4 appears to be localized to the cell membrane, and
in certain cells, the nuclear envelope (Fig. 4g and g0). Nuclear
envelope localization of Anxa4 was also previously observed in
mouse urothelium (Hill et al., 2008). Further, lower expression of
Anxa4 is detectable at the cell membrane of the acinar cells
(Fig. 4g and g0). In one-year old zebraﬁsh liver and pancreas,
Anxa4 is markedly expressed in the ductal networks (Fig. 4h and
i). In 2-month old ﬁsh, Anxa4 is also expressed in zebraﬁsh
pancreatic islets, including a subset of the cells expressing Gluca-
gon or Insulin (Fig. 4j and j0). Interestingly, in the human liver and
pancreas, ANXA4 is also expressed in ducts and islets (Dreier
et al., 1998), (www.proteinatlas.org), (Ahmed et al., 2005). Similar
Fig. 3. Knockdown of Anxa4 reduces 2F11 staining. (a) Diagram of anxa4 transcripts to depict targets of MOs and RT-PCR primers (green arrows). MO1 is targeted to block
translation initiation in Exon 3 and MO2 is targeted to block the splice donor site at the Exon 4/Intron 4 boundary, predicted to cause skipping of Exon 4, leading translation
from Exon 3 directly to Exon 5. (b) RT-PCR (with primers indicated in (a)) of control and MO2 morphant embryos showing the predicted 157 bp PCR product from the mis-
spliced transcript (red arrow) and a reduction of the 245 bp PCR product from the normally-spliced transcripts (blue arrow) in morphants. (c) The sequence of the mis-
spliced transcript conﬁrms Exon 4 skipping and indicates a premature stop codon in Exon 5. (d) Both MOs lead to reduced 2F11 staining in a western blot of whole embryo
lysate. (e)–(g0) Ventral views of 48 hpf Tg(sox17:GFP) showing that Anxa4 morphants have reduced 2F11 labeling in the entire hepatopancreas area compared to the control.
L, liver; P, pancreas; dP, dorsal pancreas.
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hepatopancreas expression of Anxa4 in zebraﬁsh, mouse, and
human suggests that foregut expression of ANXA4 is conserved,
supporting zebraﬁsh as a suitable model for investigating ANXA4
function.
Annexin A4 is required cell-autonomously for cell survival in the
developing liver
To investigate the role of Anxa4 in foregut endoderm develop-
ment, we further examined anxa4 morphants. Based on bright-
ﬁeld microscopy, 31 hpf Anxa4 morphants (3 ng of MO1 or 1.5 ng
of MO2 per embryo) are slightly shorter, with less pigmentation
compared to the standard control morphants, suggesting a mild
developmental delay (Fig. 5a–c). No other obvious body pheno-
types were observed. The pancreas and liver in Anxa4 morphants
are hypoplastic at 48 hpf. This defect may be due to the develop-
mental delay, a decrease in proliferation, and/or an apoptotic
defect (Fig. 3e–g0). By 66 hpf, endocrine cells still appear outside
the principal islet in the Anxa4 morphants (Fig. S2c and c0),
suggesting that endocrine neogenesis is not lost in Anxa4 mor-
phants. Since Anxa4 shows elevated expression in the intra-
pancreatic ducts and intra-hepatic ducts, we looked for ductal
defects in the Tg(Tp1:eGFP) background, in which the ductal cells
of the liver and pancreas are marked by GFP expression (Parsons
et al., 2009). We found the GFPþ cells in the liver and pancreas of
Anxa4 morphants Tg(Tp1:eGFP) embryos forms ductal networks
Fig. 4. Conserved zebraﬁsh and mouse Anxa4 expression in the liver and pancreas. (a)–(g0) Immunoﬂuorescent labeling of Anxa4 in the liver and pancreas of E12, E14,
and P25 mice. From E12 to E14, Anxa4 is detected in Prox1þ liver cells (a) and (c), and in all pancreatic cells (b) and (b″); (d) and (d″), including Sox9þ or Glucagonþ cells and
cells negative for both Sox9 and Glucagon (white arrowheads in b-b″). At E14, both the Sox9 high (yellow arrowheads) and low (blue arrowheads) expression cells are
positive for Anxa4. In adult mice, Anxa4 is expressed the intrahepatic biliary ducts (e) and (e0); white arrowheads) and intrapancreatic ducts (f) and (f0); white arrowheads),
co-localizing with ductal expression of E-Cadherin. Anxa4 is also expressed in pancreatic endocrine islets (g) and (g0), with localization to the membrane (white arrowhead)
and nuclear envelope (yellow arrowhead). Low level Anxa4 is expressed in acinar cells (blue arrowheads) (h)–(j0) Immunoﬂuorescent labeling of Anxa4 in the zebraﬁsh liver
(h) and pancreas (I) of one-year old Tg(ptf1a:GFP);Tg(lfabf:ds-Red), and pancreas of 2-month old Tg(ins:dsRed);Tg(gcga:GFP), showing Anxa4 is expressed in the networks of
intrahepatic (h) and intrapancreatic (i) and (j0) ducts as well as pancreatic islets (j), (j0) single optical section, white arrowheads).
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with high expression of Alcam, similar to those in the standard
control morphants. Although the ductal compartment is reduced
in size compared to controls, this reduction appears proportional
to the overall reduction of the entire liver and pancreas, suggesting
that the smaller ductal compartment in the Anxa4 morphants is
not a speciﬁc phenotype (Fig. S3a and b0). However, 2F11 labeling
shows less effective knockdown of Anxa4 by this stage. Although
higher doses of MO2 (41.5 ng) can more effectively knock down
Anxa4 expression, it can also lead to more severe developmental
delay, suggesting the MO2 may have greater off target effects
than MO1. Proliferation assays based on phosphorylated Histone
3 expression in the developing liver and pancreas did not show a
signiﬁcant difference between the Anxa4 morphants (both MO1
and MO2) and the standard control morphants at 31 hpf (not
shown). In the Tg(sox17:GFP) background, patches of blebs with
elevated GFP are present in the 31 hpf Anxa4 morphant liver bud
but not in surrounding endodermal tissue or in control morphants
(Fig. 5d–f″). These GFP blebs appear within the Prox1 expressing
hepatopancreatic domain (Fig. S4). The Prox1 domain also over-
laps with the Pdx1 expression domain, suggesting that pancreatic
progenitors may reside in this region. Cellular blebs are a hallmark
of apoptosis (Coleman et al., 2001). Due to cytoplasmic shrinkage,
GFP in these apoptotic blebs becomes more concentrated, and thus
appears brighter. Because of restricted intracellular localization
of activated Caspase 3 (Luo et al., 2010), a direct regulator of
apoptosis and blebbling (Sebbagh et al., 2001), only a subset of the
Fig. 5. Anxa4 knockdown causes stage and tissue speciﬁc apoptosis in the developing foregut. (a)–(c) Bright ﬁeld microscopy of 31 hpf standard control MO (a), Anxa4
MO1 (b) and Anxa4 MO2 (c) morphant zebraﬁsh embryos showing a mild developmental delay in the Anxa4 morphants. (d)–(f″) The ventral views of 31 hpf Tg(sox17:GFP)
foregut stained for Anxa4 and cleaved Caspase 3 (*Casp 3). In Anxa4 morphants (MO1 in (e)–(e″); MO2 in (f) and (f″), but not in control morphants (d) and (d″), Anxa4
labeling is mostly lost (e) and (f) and patches of GFPþ apoptotic blebs can be found restricted to the Anxa4 morphant liver buds (white arrowheads). A subset of these GFP
blebs are also positive for cleaved Caspase 3 (yellow arrowheads). (g) Graph summarizing relative incidence of liver apoptosis in anxa4 morphants, which peaks at 31 hpf.
(h) Graph of a representative set of real-time RT-PCR results showing that in 27 hpf Anxa4 MO1 morphants, there is elevated expression of caspase 8 and Δ113p53.
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GFP blebs are positive for activated Caspase 3 (Fig. 5e″ and f″).
Increased activated Caspase 3 was not observed in tissues that do
not express Anxa4. Further, in Anxa4 morphants, there is no
signiﬁcant detectable cell death in other Anxa4-expressing tissue
such as the dorsal pancreas, which show almost no GFP blebs
(498% in MO1 morphants, n¼53). These ﬁndings indicate that
there is liver bud speciﬁc apoptotic cell death in Anxa4 morphants
and suggest that liver progenitor cell survival is particularly
sensitive to decreased Anxa4 expression. Among either MO1 or
MO2 morphants, more than 60% showed patches of blebs in the
liver buds. Stage speciﬁcity of the liver bud apoptosis is also
similar for both morphants. Although liver bud apoptosis can be
found between 27 and 40 hpf, the peak penetrance occurs at
31 hpf (Fig. 5g). This stage correlates with the increase of Anxa4
expression in the developing liver buds (Fig. 1d and e). Because
apoptosis is restricted to the liver bud only 1–2 h before the
ventral pancreas progenitors become detectable, it is not clear why
the pancreas in Anxa4 morphants is also hypoplastic. One possi-
bility is that pancreas progenitors are co-opted to adopt liver fate
to help compensate for liver cell loss. Alternatively, it is possible
that some apoptotic cells in the liver bud are pancreas progenitors.
Although ventral pancreatic progenitors are believed to arise from
an area immediately adjacent to the liver bud, whether some
pancreas progenitors also reside within the liver bud is unknown.
Consistently, earliest markers of the liver bud, prox1 and hhex, are
not speciﬁc to the liver but also are expressed in the ventral
pancreas.
To elucidate the molecular mechanism of apoptosis in Anxa4
morphants, we examined the effect of Anxa4 knockdown on the
expression of key apoptosis related genes by real-time RT-PCR. We
found that caspase 8 but not caspase 9 transcripts in MO1
morphants were increased by nearly 2 fold over standard control
morphants (Fig. 5h). This suggests that in Anxa4 morphants,
cell death occurs through the extrinsic, and not the intrinsic,
apoptotic pathway (Elmore, 2007). Interestingly, we found that the
transcripts of the Δ113p53 isoform increase more than 5 fold.
Δ113p53, an anti-apoptotic isoform of p53 in zebraﬁsh, has been
reported to antagonize p53-mediated apoptosis via Bcl-xL
under stress conditions, speciﬁcally in the developing digestive
system (Chen et al., 2009, 2005; Dong et al., 2007; Lorent et al.,
2010; Matthews et al., 2008). The increased expression of the
anti-apoptotic Δ113p53 transcripts may indicate a foregut
speciﬁc compensatory mechanism in response to the liver speciﬁc
apoptosis caused by Anxa4 knockdown. Although our results
showed a consistent decrease of p53 transcripts in Anxa4 mor-
phants, the level of reduction was mild and insigniﬁcant. Despite
the fact that in vitro studies suggest that Anxa4 interacts directly
with the NFκB p50 subunit to affect its transcriptional targets
(Jeon et al., 2010), we observed no signiﬁcant difference for NFkb
target genes, such as bcl-XL, c-Flip and iκBα (bcl2l, cﬂara and
nfkbiaa in zebraﬁsh respectively), between Anxa4 morphants and
controls.
It is possible that the whole-embryo knockdown of Anxa4
function via MO disrupts liver development indirectly by affecting
other tissues. Anxa4 transcripts are expressed broadly before and
during gastrulation in zebraﬁsh. Further, Anxa4 is also expressed
speciﬁcally at 24 hpf in the ﬂoor plate and hypochord (data not
shown), which are important midline signal sources for patterning
the surrounding tissue (Crosier et al., 2002; Placzek and Briscoe,
2005). To determine whether Anxa4 function is required in the
endoderm to cell-autonomously support liver cell survival, we
utilized an endoderm transplantation technique to knock down
Anxa4 expression only in the endoderm. This cell transplantation
technique utilizes sox32 mRNA to induce endoderm fate in
the entire donor embryo (Stafford et al., 2006). Transplanted
donor cells, labeled with rhodamine dextran, will then contribute
predominantly to the host endoderm (Fig. 6a and b). By co-
injecting sox32 mRNA and anxa4 MOs into donor embryos, the
resulting mosaic host embryos will contain donor derived endo-
derm cells with reduced Anxa4 expression.
Wild type control donor cells without anxa4 MOs appeared
morphologically normal in 48 hpf Tg(sox17:GFP) host endoderm
(Fig. 6c and c0), with the rhodamine signal showing clear cell
shapes. However at this stage, in the host embryos with donor
cells containing anxa4 MO1 (3 ng), the rhodamine signal was no
longer focused into distinct cell shapes, but appeared diffuse
throughout the host foregut endoderm (Fig. 6d and d0). We posit
that the scattered rhodamine signal may be indicative of remnants
of the donor cells that have undergone apoptosis at an earlier
stage. Consistent with this postulation, we noted above that liver
apoptosis in Anxa4 morphants is most penetrant at 31 hpf, leading
us to examine mosaic morphants at this earlier stage. To be more
certain that donor cells are of endoderm origin, anxa4 MO1 was
injected into Tg(sox17:GFP) embryos and transplanted into non-
transgenic wild-type host embryos. In the resulting mosaic
embryo, the GFP positive endoderm cells are from anxa4 MO1
injected donors. At 31 hpf, as expected, GFP positive morphant
donor cells lack Anxa4 expression in contrast to surrounding wild-
type host endoderm cells (Fig. 6f″ and g″), with most of those
morphant cells still intact. In these host embryos, GFP positive
blebs were detected in the liver (100% of the mosaic livers, n¼9)
but not dorsal pancreas (0% of the mosaic dorsal pancreas, n¼7).
Consistently, cleaved Caspase 3 can be detected in a subset of the
GFP positive cells in the liver but not in either the dorsal pancreas
or in GFP negative surrounding cells (Fig. 6e–g″), further support-
ing that liver bud cell survival is more sensitive to decreased
Anxa4 function than other tissues. Although only a subset of the
morphant clones in the liver appears to be apoptotic at this early
stage, our observation that in most cases, intact morphant donor
cells are not found in the liver at later stages, suggests that most
morphant clones within the liver are gradually lost as foregut
development proceeds.
As a complementary approach for the Anxa4 mosaic knock-
down studies, mosaic knockout of anxa4was also examined after a
transient application of the CRISPR/Cas9 nuclease targeting sys-
tem. Injection of CRISPR/Cas9 can lead to frequent bi-allelic
disruption of the targeted genetic sequence in random cells of
an embryo, thereby achieving a genetically mosaic animal (Jao et
al., 2013; Jinek et al., 2012). In taking this approach, one guide RNA
was designed to target a region in Exon 3 of anxa4, which contains
a restriction site for the enzyme Ddel (Fig. 7a). Co-injection of this
guide RNA with cas9 mRNA into embryos leads to disruption of
this restriction site (Fig. 7b). To conﬁrm if the induced mutations
lead to a signiﬁcant disruption of the Anxa4 protein expression in
a mosaic manner, 2F11 staining was assessed in the ﬂoor plate,
where Anxa4 expression is consistent. In control embryos, Anxa4
is expressed broadly throughout the ﬂoor plate in a continuous
stripe pattern. However, injected embryos exhibit gaps of Anxa4
expression in the ﬂoor plate (Fig. 7c and d), suggesting that certain
clones of cells have lost any detectable Anxa4 expression, further
validating the effectiveness of the guide RNA designed. Upon
examination of the foregut of Tg(sox17:GFP) embryos injected with
anxa4 guide RNA and cas9 mRNA, apoptotic GFP blebs and cleaved
Caspase 3 expression were observed (25% of anxa4 CRISPR injected
embryos, n¼12). The apoptotic cell death occurs in the Anxa4
negative region of the liver anlagen but not in other areas of the
foregut endoderm, consistent with the mosaic knockdown studies
(Fig. 7e–f″0). Similar results were found with two other guide RNAs
targeting either Exon 2 or 4 of anxa4 (data not shown). Together,
these mosaic knockdown and knockout studies suggest that
Anxa4 is required cell-autonomously for cell survival in the early
developing liver.
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Discussion
We have deﬁnitively identiﬁed the molecular target bound by
the 2F11 mAb, demonstrating an effective strategy for determining
the target of an antibody with an unknown antigen. Via peptide
mass ﬁngerprinting, we initially identiﬁed a strong candidate
target for 2F11 mAb. By knocking down the candidate protein
expression, we functionally conﬁrmed the identity of the factor
recognized by 2F11 mAbs. This approach may be generally useful
for determining the targets of other orphan antibodies. With the
efﬁciency of this strategy, it may now be more practical to screen
for new factors by generating random monoclonal antibodies
against extracts from cells of interest and determining their targets
using the approach described here. Coupled with the use of
traditional MO knockdown approaches and modern genome edit-
ing tools such as TALENs (Zu et al., 2013) and CRISPR/Cas (Hwang
et al., 2013) for mutant functional studies of the newly identiﬁed
factors, as demonstrated in this work, an antibody screen should
now be considered a more practical approach for gene discovery.
The 2F11 mAb has become an essential reagent for labeling
zebraﬁsh hepatopancreatic ducts and intestinal secretory cells. By
uncovering Anxa4 as the target of 2F11, we shed new light on
published studies and future studies utilizing this antibody. With
our ﬁndings that mAb 2F11 labels the hepatopancreas anlagen and
pancreas islets, and other tissues including the pronephric ducts,
ﬂoor plate, hypochord, swimbladder mesenchyme, and lateral
Fig. 6. Anxa4 is cell-autonomously required for liver cell viability. (a) Diagram depicts endoderm transplantation strategy. Donor embryo is injected with sox32mRNA to
drive endoderm fate, rhodamine dextran for labeling, and MOs to knock down gene expression. At 4 hpf, donor cells are transplanted into a host embryo, where they will
contribute primarily to the host endoderm. (b) The mosaic 35 hpf host embryo obtained after the endoderm transplantation contains rhodamine dextran labeled donor
endoderm cells (white arrows). (c) and (d0) The ventral view of 48 hpf Tg(sox17:GFP) foregut with rhodamine dextran labeled WT (white arrowheads in (c) and (c0) or anxa4
morphant donor cells (d) and (d0). L, liver; P, pancreas. Note that rhodamine labeling (white arrowheads in (d) and (d0)) appears scattered and not restricted within individual
cells in the host embryo with Anxa4 morphant donor cells. (e)–(g″) A single optical section (ventral view) of a 31 hpf mosaic host embryo with Anxa4 morphant cells from a
Tg(sox17:GFP) donor embryo showing GFP blebs in the liver (upper inset and (f) and (f″) but not dorsal pancreas (lower inset and (g) and (g″). Subsets of GFP positive
morphant donor cells are also positive for the cleaved Caspase 3 (white arrows) in the liver but not the dorsal pancreas. L, liver; dP, dorsal pancreas.
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lines, we expect this reagent to be increasingly useful for the
zebraﬁsh research community. Further with our results showing
conserved expression of Anxa4 in mouse, we expect that assaying
for Anxa4 expression to become a new approach for robustly
labeling tissues such as ducts of pancreas, liver, and kidney in
mammalian models.
Conserved expression of Anxa4 among vertebrates suggests
that its function may also be similar. Our investigation of Anxa4
Fig. 7. Mosaic disruption of the anxa4 gene by CRISPR/Cas9 leads to apoptosis in the developing liver. (a) The CRISPR guide RNA is designed to target a region in Exon
3 of anxa4, which contains a DdeI restriction enzyme site. The red lines indicate the guide RNA target site. Orange arrows indicate the primers for the genotyping PCR. (b)–
(d) Effective anxa4 disruption by CRISPR/Cas9 was conﬁrmed by DdeI digestion of the PCR products (b) and by Anxa4 antibody labeling of the ﬂoor plate (c) and (d). An uncut
band (green arrow in (b)) and the ﬂoor plate cells without Anxa4 expression (white arrowheads in (d)) are found only in injected embryos. Yellow arrows point to ﬂoor plate
(fp) in (c) and (d). (e) and (f″0) Confocal projections showing that apoptosis, indicated by GFP blebs and cleaved Caspase3 labeling, occurs in a subset of liver cells where
Anxa4 expression is disrupted in the CRISPR injected embryos (white arrows) but not in control embryos.
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function shows that knockdown of Anxa4 in zebraﬁsh embryos,
using either of two functionally validated MOs, leads to the same
cell-autonomous, stage and tissue speciﬁc apoptotic phenotype in
the developing liver bud, consistent with when and where Anxa4
is expressed. This tissue speciﬁc phenotype is not likely due to MO
toxicity as observed with certain MOs. Apoptosis resulting from
MO toxicity generally lacks spatiotemporal speciﬁcity and shows
increased p53 transcription (Gerety and Wilkinson, 2011), which
we did not observe (Fig. 5h). Further, it is unlikely that both
validated MOs would cause the same tissue speciﬁc, off-target
effect. Experiments to rescue morphants via over expression of
wild type Anxa4 were inconclusive, likely due to the difﬁculty in
replicating Anxa40s high expression level and dynamic, tissue
speciﬁc expression pattern. However, our transient studies using
the CRISPR/Cas9 system to knockout anxa4 in random cell popula-
tions during embryogenesis provide strong corroborative data.
Assuming complete knockout of anxa4 is not gastrulation lethal,
depending on its function during its early broad expression, future
work generating and analyzing stable anxa4 mutants will be
important for comparing and contrasting the effect of mosaic
anxa4 knockout during development versus complete anxa4
knockout throughout development. Although anxa4 is also
expressed in other tissues such as the ﬂoor plate, lateral line,
pronephric duct, and more prominently in the dorsal pancreas, we
did not detect signiﬁcant cell death in these tissues in Anxa4
morphants. These tissues may be less sensitive to decreased Anxa4
function, perhaps due to redundancy with other Annexins. Alter-
natively, complete loss of Anxa4 function may be necessary to
yield detectable defects in these tissues. It is also possible that
Anxa4 is not required for cell survival in these tissues, but may
play other roles yet to be discovered. Its dynamic intracellular
localization in different tissues at different stages may be indica-
tive of multiple functions for Anxa4. Consistent with previous
studies, liver cell survival appears to be particularly sensitive to
loss of several other factors, including RelA, IKKβ, or NEMO/IKKγ
of the NFκB signal pathway (Beg et al., 1995; Rudolph et al., 2000;
Tanaka et al., 1999), and SNX7 (Xu et al., 2012), suggesting that
liver cell survival is a highly regulated process. It may be that these
factors act together to regulate liver cell survival. However unlike
many of these other factors, which exhibit broader expression
within the foregut, Anxa4 shows more restricted liver bud expres-
sion, suggesting that cell survival is speciﬁcally regulated in
this organ.
Although Anxa4 and other members of the Annexin family
have been implicated in cell survival, our studies provide the ﬁrst
in vivo data to implicate Anxa4 in this process. A role for Anxa4 in
cell viability may have implications for ß-cell and cancer cell
survival. Loss of the insulin producing, pancreatic ß-cells is
characteristic of nearly all forms of diabetes. Intriguingly, the
expression of ANXA4 is positively regulated by several MODY
(Maturity Onset Diabetes of the Young) genes, including PDX1,
HNF1A, and HNF4A (Bolotin et al., 2010; Servitja et al., 2009;
Svensson et al., 2007). Because our studies implicate Anxa4 in cell
survival, it will be interesting to investigate whether ß-cell death
and decreased ß-cell ANXA4 expression are characteristic of these
monogenic forms of diabetes. Although we found that loss of
Anxa4 did not lead to apoptosis of embryonic ß-cells, it will be
important to examine Anxa4 function in stressed adult ß-cells,
where Anxa4 may be needed for cell survival.
Elevated levels of Anxa4 have been associated with many
cancers, including pancreatic ductal adenocarcinoma (Shen et al.,
2004), renal clear cell carcinoma (Zimmermann et al., 2004),
gastric cancer (Lin et al., 2008), ovarian clear cell carcinoma
(Miao et al., 2009; Toyama et al., 2012), and colorectal carcinoma
(Duncan et al., 2008), and have been suggested as a diagnostic
biomarker for these cancers. Cell culture studies suggest that
Anxa4 promotes cell migration (Zimmermann et al., 2004) and
proliferation (Lin et al., 2008) but represses apoptosis induced by
chemotherapy drugs. Our ﬁndings are consistent with an anti-
apoptotic role for Anxa4, leading us to suggest future in vivo
studies to determine whether elevated Anxa4 is sufﬁcient to
confer chemoresistance.
Materials and methods
Zebraﬁsh strains
Zebraﬁsh were raised and maintained under standard condi-
tions. The following transgenic lines were used: Tg(sox17:GFP)s870
(Mizoguchi et al., 2008) Tg(neuroD:EGFP)nl1 (Obholzer et al., 2008);
Tg(ptf1a:GFP)jh1 (Godinho et al., 2005); Tg(lfabf:ds-Red, elaA:
EGFP)gz12 (Korzh et al., 2008; Pisharath et al., 2007); Tg(ins:
dsRed)m1081 (Anderson et al., 2009); Tg(gcga:GFP)ia1 (Pauls et al.,
2007); Tg(Tp1bglob:eGFP)um14 (Parsons et al., 2009), abbreviated as
Tg(Tp1:eGFP).
Immunohistochemistry (IHC)
IHC was performed as previously described for zebraﬁsh (Dong
et al., 2007) and for mouse parafﬁn sections (Lee et al., 2007).
Antibodies used include mouse monoclonal 2F11 (Crosnier et al.,
2005) (1:1000; gift from J. Lewis, Cancer Research UK), rabbit
polyclonal against Prox-1 (1:200; Millipore), rabbit polyclonal
antibody against pan-Cadherin (1:5000; Sigma); rabbit polyclonal
against GFP (1:300; Torrey Pines Biolabs), rabbit polyclonal against
cleaved Caspase 3 (1:50, Cell Signaling), goat polyclonal against rat
Anxa4 (1:50 Santa Cruz Biotechnology), rabbit polyclonal against
Sox9 (1:50 Chemicon International), rabbit monoclonal against
E-Cadherin (1:200 Cell Signaling). Control and morphant embryos
were stained in the same tube. Imaging was done with a Zeiss 710
confocal microscope with Zen 9 software and images were
processed with Adobe Photoshop CS3.
Immunoprecipitation and proteomics
100 embryos of 72 hpf were dissolved in 1 ml lysis buffer
(20 mM Tris–HCl, 150 mM NaCl, 1% deoxycholate, 1% IGEPAL, pH
7.4) supplemented with protease inhibitor mixture set III (Sigma),
1 mM phenylmethylsulfonyl ﬂuoride and 10 mM EDTA on ice for
30 min. The lysate was then clariﬁed by centrifugation at 10,000g
for 30 min at 4 1C. Then 1 mg of 2F11 antibody was added and
incubated 2 h at 4 1C (with constant rotation). The precipitated
protein was captured on protein G agarose beads (20 ml) at 4 1C
overnight, with rotation. The beads were washed 5 times with
lysis buffer and the protein was eluted with PAGE sample buffer.
After 4–20% PAGE, the proteins were stained with SimplyBlue
SafeStain (Invitrogen). The protein band was excised from the gel
and subjected to in-gel trypsin digestion with Trypsin Gold, Mass
Spectrometry Grade trypsin (Promega). The digest samples were
analyzed by LC/MS/MS using the LTQ XL Linear Ion Trap Mass
Spectrometer (Thermo Scientiﬁc). To identify the protein MS/MS
spectra were searched against the Swiss-Prot database using
SEQUEST Sorcerer software.
Whole mount in situ hybridization (ISH)
Zebraﬁsh embryo whole mount ISH was performed as pre-
viously described (Lancman et al., 2013). Following ISH, IHC for
GFP was carried out as reported with minor modiﬁcation (Huang
et al., 2008). Imaging was conducted using a Zeiss 710 confocal
microscope with AxioPlan 4.8 software. The bright ﬁeld and
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ﬂuorescent images of ISH and IHC, respectively, were captured
with the same vision ﬁeld and magniﬁcation of individual sam-
ples, and merged with Abode Photoshop CS3. The anxa4 anti-sense
probe was generated corresponding to the segment from PstI to
BglII in anxa4 cDNA clone (MGC: 64121).
Morpholino injections
The embryos were injected at one to two cell stages with 3 ng
Anxa4 MO1, 1.5 ng Anxa4 MO2, or 3 ng standard control MO
(GENE TOOLS, LLC.). The morphonlino injection into 48 hpf
embryos did not effectively reduce 2F11 antibody labeling. Anxa4
MO1 has the sequence of TTC CAC GGT TTC CCA ACG CTG CCA T
and MO2 has the sequence of TGG TAT GGT CTC TCT CAC CTG CTC
C. Standard control MO has the sequence of cctcttacctcagttacaatt-
tata. The primers used in RT-PCR for testing the efﬁcacy of Splice
MO are 50-cttcatctctacaatggcagcg-30 and 50-agtttccagtcagctcaga-30.
Real-time PCR
Total RNA was extracted from 20 to 30 zebraﬁsh embryos
collected at 27 hpf using Tri-reagent (Molecular Research Center,
Inc). 5 mg total RNA was used as the template and reverse
transcribed with oligo-dT primer using Improm-II Reverse tran-
scriptase in 20 ml reaction as indicated by the product manual. The
real-time PCR was performed as described with minor modiﬁca-
tions (Correa et al., 2005). The following primers were determined
through Roche online universal probe library Assay Design Center:
cﬂara (NM_194399, 50-ctg tgc ctg aaa cag gga tt-30 and 50-cgt gtg
ctt caa cat ttc tcc-30), bcl2l (NM_131807.1, 50-ggc ttg ttt gct tgg ttg
ac-30 and 50-tgg tgc aat ggc tca tac c-30), p53 (NM_131327.1, 50-gag
gtc ggc aaa atc aat tc-30, 50-cac ctg ggg gct gaa taa t-30), caspase 8
(NM_131510.2, 50-tca gag tca cag aga cca gga a-30, 50-cag ata cag
ggt tgt tga gaa aaa-30), caspase 9 (NM_001007404.2, 50-aaa ggg ggt
ctt cac tca gg-30, 50-gtt gcc tgg ctt ggt cac-30). The primers for
Δ113p53 isoform (50-ATA TCC TGG CGA ACA TTT GGA G-30, 50-CCT
CCT GGT CTT GTA ATG TCA-30), nfkbiaa (50-CAG CAC CTG CGT TCC
ATT CT-30 and 50-GCA CGT GTG TCC GCT GTA GT-30) and cyclophilin
(50-GAC GAT GCT GTT CGC TAC CA-30 and 50-CAA GCG CAC GTA
GCC TTT CT-30) are as described (Xu et al., 2012; Correa et al.,
2005). Results were normalized to cyclophilin.
Endoderm transplantation
The procedure was performed as previously described (Stafford
et al., 2006). Brieﬂy, embryos injected with sox32 Mrna (and MOs)
at the one cell stage were used as donors. At 4 hpf, both donor and
host embryos were dechorioned in an agarose-coated petri dish.
Donor cells were drawn into a glass needle (pulled from Borosi-
licate Glass Capillaries, World Precision Instruments, Inc) using
CellTram Air (Eppendorf). About 15 donor cells were then injected
into one host embryo using CellTram Air.
Targeting the anxa4 gene with the CRISPR/Cas9 system
The targeting sites (50-GGA ACT GTG ACT GAG GCG TC-30 for
Exon 2; 50-GGA GGC TTT CAA GCT GAG CG-30 for Exon 3; 50-GGG
CCT GAT GAT GCC TGC AG-30 for Exon 4) were selected using the
online application available at ziﬁt.partners.org. The guide RNAs
were produced and injected with cas9 mRNA as previously
described (Jao et al., 2013). The following primer pairs and
restriction enzymes were used for assessing genetic disruption:
50-GAT CCT TGA CAC AGT CTG ATC T-30, 50-CTG AGT AGT TGG CGG
TTC A-30 and DdeI for Exon 2; 50-CTT AGG CTT TGA CTG ATG CCA-
30, 50-GGT TGC TGA AGA ACT ACT GAG A-30 and DdeI for Exon 3;
50-CCT CAC CCA CAC TTT GCC T-30, 50-GTA CAC TGA TGG ACT ACA
GAC A-30 and PstI for Exon 4.
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